Clinical and epidemiological features of the first reported outbreaks of feline calicivirus virulent systemic disease in Australia and in vitro efficacy of three antiviral compounds: nitazoxanide, 2'-Cmethylcytidine and NITD-008 Cats presenting with ≥1 sign consistent with FCV-VSD during the outbreaks were included.